Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07376070

The Role of Inflammatory Biomarkers in Preventing Deep Sternal Wound Infections After Sternotomy

The goal of this observational study is to reveal blood biomarkers that will have prognostic significance in terms of the development of deep wound infection following sternotomy. As for the practical significance of the study, blood biomarkers correlated with deep wound infections can be used to prevent the development of wound infections in the postoperative period. Based on this, it is possible to formulate an algorithm for preventive measures.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Bokhua memorial cardiovascular center, Tbilisi, Georgia

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • deep sternal wound infection

Exclusion criteria

  • bilateral internal thoracic artery graft

Treatment and study plan

Primary outcomes

  1. change in pre and postoperative inflammatory biomarker levels associated with development of deep sternal wound infection within 1 month

    Time frame: within 30 days after surgery

Sponsors and collaborators

Lead sponsor

Levan Nebieridze

Other

Registry information

Important dates

Study start
2025
Primary completion
2026
Study completion
2028
First posted
Jan 29, 2026
Registry last updated
Jan 29, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.